Ophthalmos Research and Educational Institute investigate the effects of high doses of omega 3 fatty acids in macular degenerations, optic neuropathies and dry eyes. We have recently been able to demonstrate that dietary intake of omega 3 fatty acids at a specific dose so that the blood AA/EPA ratio is within a therapeutic range can protect against macular degenerations and optic neuropathies in murine models. Dr Tassos Georgiou is the head of the Research department and is currently the Principal Investigator of a multicentre phase 2  clinical study in Europe to investigate the effects of the patented omega 3 fatty acids on dry macular degeneration and a multicentre phase 2 clinical study in Europe for Stargardt disease. A phase 3 clinical study is towards the end in USA sponsored by the National Eye Institute to study the effects of the patented omega 3 fatty acid on dry eyes.